Skip to content
← Holders

EcoR1 Capital, LLC

What EcoR1 Capital, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1587114 · Filed Nov 16, 2026

Positions
36
Reported value
$2.3B
Opened
13
Closed
10
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$2.1B
    30 positions
  2. Dec 31, 2025$2.2B
    30 positions
  3. Mar 31, 2026$2.4B
    30 positions
  4. Jun 30, 2026$2.1B
    33 positions
  5. Sep 30, 2026$2.3B
    36 positions
SecuritySharesChangeValueOf portfolio
ZYMEZymeworks Inc.
23M±0%$608.5M27%
ANABAnaptysbio, Inc
7.9M±0%$396.1M17.6%
BMYBristol Myers Squibb CoCall option
3.5MNew$218.4M9.7%
CGONCG Oncology, Inc.
1.9M+25.3%$132.7M5.9%
ETONEton Pharmaceuticals, Inc.
2.5M+13.8%$127.2M5.6%
TRAXFirst Tracks Biotherapeutics, Inc.
3.2MNew$112.5M5%
AKTSAktis Oncology, Inc.
4.8M±0%$93.9M4.2%
CRSPCRISPR Therapeutics AG
1.4M±0%$76.9M3.4%
ANROAlto Neuroscience, Inc.
2.2MNew$57M2.5%
LKFTLakefront Biotherapeutics NV
1.7M±0%$49.4M2.2%
ERASErasca, Inc.
3M+793.9%$43.2M1.9%
ORICOric Pharmaceuticals, Inc.
3M−55.0%$40.8M1.8%
NGNENeurogene Inc.
1.3M±0%$35.4M1.6%
ATTOAttovia Therapeutics, Inc.
2MNew$34.7M1.5%
FULCFulcrum Therapeutics, Inc.
6.8M+3.9%$25.2M1.1%
ADRXADARx Pharmaceuticals, Inc.
1.2MNew$22.9M1%
STOKStoke Therapeutics, Inc.
835K+13.6%$21.7M1%
ZBIOZenas BioPharma, Inc.
789.5K±0%$21.3M0.9%
ETRAElectra Therapeutics, Inc.
1.7MNew$19.1M0.8%
ATRAAtara Biotherapeutics, Inc.
1.6M±0%$13.2M0.6%
CAPRCapricor Therapeutics, Inc.
1.4MNew$13M0.6%
XNCRXencor Inc
500KNew$12.5M0.6%
ODTXOdyssey Therapeutics, Inc.
555.6KNew$12.3M0.5%
AURAAura Biosciences, Inc.
1.7M±0%$10.5M0.5%
NRIXNurix Therapeutics, Inc.
375K+38.9%$8.9M0.4%
BRVEBraveheart Bio, Inc.
416.7KNew$8.4M0.4%
PHVSPharvaris N.V.
235K±0%$7.5M0.3%
EIKNEikon Therapeutics, Inc.
855.6K+16.8%$6.9M0.3%
ELOXEloxx Pharmaceuticals, Inc.
400KNew$6.1M0.3%
AARDAardvark Therapeutics, Inc.
720K+81.7%$3.8M0.2%
BBOTBridgeBio Oncology Therapeutics, Inc.
889.6K−68.5%$3.6M0.2%
TCGXTCGX Acquisition Corp.
250KNew$3.1M0.1%
ZURAZura Bio Ltd
679.7K−42.4%$2.8M0.1%
HLXCHelix Acquisition Corp. III
200K±0%$2.1M0.1%
CTNMContineum Therapeutics, Inc.
64.3KNew$862.9K0.1%
CGONCG Oncology, Inc.Call option
100−100.0%$7.1K0.1%